[1] Stolz AJ, Harustiak T, Simonek J, et al. Pneumonectomy
for non-small cell lung cancer:predictors of early mortality
and morbidity [J]. Acta Chir Belg, 2014,14(1):25-30.
[2] Toshiyuki N, Kimura T, Suzumura T, et al. The Macroscopic
appearance of computed tomography—guided needle
biopsy specimens correlates with tumor metastasis in nonsmall
cell lung cancer [J]. Osaka City Med J, 2015,61(2):
105-112.
[3] 刘启飞. 循环miRNA- 21 在肿瘤中的研究进展[J]. 医学综述,
2014,20(19):3521-3523.
[4] Gillis AJ, Rijlaarsdam MA, Eini R, et al. Targeted serum
miRNA(TSmiR)test for diagnosis and follow- up of (testicular)
germ cell cancer patients: a proof of principle [J]. Mot
Oneol, 2013,7(6):1083-1092.
[5] Zou XN, Wan X, Dai Z, et al. Epidemiological characteristics
of cancer in elderly Chinese [J]. ISRN Oncol, 2012,
38(18):49-50.
[6] 周莹,刘士远.美国国立综合癌症网肺癌筛查指南解读(2012)[J].
肿瘤影像学,2013,22(4):331-335.
[7] Li R, Pu X, Chang JY, et al. MiRNA- related genetic
variations associated with radiotherapy- induced toxicities in
patients with locally advanced non- small cell lung cancer
[J]. PLoS One, 2016,11(3):e0150467.
[8] 许晶晶,杨廷桐.miRNA 在非小细胞肺癌血清中的研究进展[J].
临床肺科杂志,2013,18(4):726-728.
[9] Zhang JG, Wang JJ, Zhao F, et al. miRNA- 21 (miR-
21) represses tumor suppressor PTEN and promotes
growth and invasion in non- small cell lung cancer
(NSCLC) [J]. Clini Chimi Acta, 2010,411(11-12):846-852.
[10] Wei J, Liu L K, Gao W, et al. Reduction of plasma MicroRNA-
21 is associated with chemotherapeutic response
in patients with non- small cell lung cancer [J]. Chin J
Cancer Res, 2011,23(2):123.